How Do You Value A Private Company? The Answer CouldAffectMartin Shkreli’s Fate

The trial of “pharma bro” Martin Shkreli, accused of defrauding his hedge fund investors and misusing funds from a company he founded, Retrophin Pharmaceuticals, took a turn to a topic near and dear to a Forbes reporter’s heart: how the heck do you value a company that is not publicly traded?

Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive